1.Risk factors for bronchopulmonary dysplasia in twin preterm infants:a multicenter study
Yu-Wei FAN ; Yi-Jia ZHANG ; He-Mei WEN ; Hong YAN ; Wei SHEN ; Yue-Qin DING ; Yun-Feng LONG ; Zhi-Gang ZHANG ; Gui-Fang LI ; Hong JIANG ; Hong-Ping RAO ; Jian-Wu QIU ; Xian WEI ; Ya-Yu ZHANG ; Ji-Bin ZENG ; Chang-Liang ZHAO ; Wei-Peng XU ; Fan WANG ; Li YUAN ; Xiu-Fang YANG ; Wei LI ; Ni-Yang LIN ; Qian CHEN ; Chang-Shun XIA ; Xin-Qi ZHONG ; Qi-Liang CUI
Chinese Journal of Contemporary Pediatrics 2024;26(6):611-618
		                        		
		                        			
		                        			Objective To investigate the risk factors for bronchopulmonary dysplasia(BPD)in twin preterm infants with a gestational age of<34 weeks,and to provide a basis for early identification of BPD in twin preterm infants in clinical practice.Methods A retrospective analysis was performed for the twin preterm infants with a gestational age of<34 weeks who were admitted to 22 hospitals nationwide from January 2018 to December 2020.According to their conditions,they were divided into group A(both twins had BPD),group B(only one twin had BPD),and group C(neither twin had BPD).The risk factors for BPD in twin preterm infants were analyzed.Further analysis was conducted on group B to investigate the postnatal risk factors for BPD within twins.Results A total of 904 pairs of twins with a gestational age of<34 weeks were included in this study.The multivariate logistic regression analysis showed that compared with group C,birth weight discordance of>25%between the twins was an independent risk factor for BPD in one of the twins(OR=3.370,95%CI:1.500-7.568,P<0.05),and high gestational age at birth was a protective factor against BPD(P<0.05).The conditional logistic regression analysis of group B showed that small-for-gestational-age(SGA)birth was an independent risk factor for BPD in individual twins(OR=5.017,95%CI:1.040-24.190,P<0.05).Conclusions The development of BPD in twin preterm infants is associated with gestational age,birth weight discordance between the twins,and SGA birth.
		                        		
		                        		
		                        		
		                        	
2.Integrated management during the perinatal period for total anomalous pulmonary venous connection.
Yi SUN ; Si-Lin PAN ; Zhi-Xian JI ; Gang LUO ; Hao WAN ; Tao-Tao CHEN ; Ai ZHANG ; Rui CHEN ; Quan-Sheng XING
Chinese Journal of Contemporary Pediatrics 2023;25(5):502-507
		                        		
		                        			OBJECTIVES:
		                        			To evaluate the clinical effectiveness of integrated management during the perinatal period for fetuses diagnosed with total anomalous pulmonary venous connection (TAPVC) by prenatal echocardiography.
		                        		
		                        			METHODS:
		                        			Clinical data of 64 cases of TAPVC fetuses diagnosed by prenatal echocardiography and managed with integrated perinatal care in Qingdao Women and Children's Hospital from January 2017 to December 2021 were retrospectively analyzed. Integrated perinatal care included multidisciplinary collaboration among obstetrics, fetal medicine, ultrasound, pediatric cardiology, pediatric anesthesia, and neonatology.
		                        		
		                        			RESULTS:
		                        			Among the 64 TAPVC fetuses, there were 29 cases of supracardiac type, 27 cases of intracardiac type, 2 cases of infracardiac type, and 6 cases of mixed type. Chromosomal analysis was performed in 42 cases, and no obvious abnormalities were found. Among the 64 TAPVC fetuses, 37 were induced labor, and 27 were followed up until term birth. Among the 27 TAPVC cases, 2 cases accepted palliative care, 2 cases were referred to another hospital for treatment and lost to follow-up, while the remaining 23 cases underwent primary repair surgery. One case died within 6 months after the operation due to low cardiac output syndrome, while the other 22 cases were followed up for (2.1±0.3) years with good outcomes (2 cases underwent a second surgery within 1 year after the first operation due to anastomotic stenosis or pulmonary vein stenosis).
		                        		
		                        			CONCLUSIONS
		                        			TAPVC fetuses can achieve good outcomes with integrated management during the perinatal period.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Echocardiography
		                        			;
		                        		
		                        			Heart Defects, Congenital/surgery*
		                        			;
		                        		
		                        			Pulmonary Veins/surgery*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Scimitar Syndrome/surgery*
		                        			;
		                        		
		                        			Infant, Newborn
		                        			
		                        		
		                        	
3.DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines.
Ya-Hui ZHAO ; Wei JIANG ; Hai GAO ; Guo-Zheng PANG ; Yu-Shuang WU ; Yuan-Xian WANG ; Meng-Yao SHENG ; Jia-Ying XIE ; Wan-Ling WU ; Zhi-Jian JI ; Ya-Rui DU ; Lei ZHANG ; Xiao-Qin WANG ; Colum P WALSH ; Hai JIANG ; Guo-Liang XU ; Dan ZHOU
Protein & Cell 2023;14(7):532-537
4.Efficacy of transcatheter pulmonary valve perforation in neonates with pulmonary atresia with intact ventricular septum.
Si Bao WANG ; Si Lin PAN ; Gang LUO ; Zhi Xian JI ; Ai LIU ; Yue Yi REN
Chinese Journal of Pediatrics 2023;61(2):126-130
		                        		
		                        			
		                        			Objective: To explore the efficacy and safety of transcatheter pulmonary valve perforation in the treatment of neonatal pulmonary atresia with intact ventricular septum (PA-IVS). Methods: The clinical data on surgical treatment and follow-up in 16 patients with PA-IVS who underwent transcatheter pulmonary valve perforation in Women and Children's Hospital, Qingdao University from October 2018 to October 2021 were analyzed retrospectively. The right ventricular systolic pressure and percutaneous oxygen saturation (SpO2) were compared before and after operation. In addition, the SpO2 and echocardiographic data at preoperative and the last follow-up were compared. Comparisons between groups were performed using paired-samples t test. Results: Among the 16 patients (10 males and 6 females) with the age at operation of 19 (14, 26) days, 12 cases underwent transcatheter pulmonary valve perforation successfully, 2 cases were transferred to surgery department for open-heart pulmonary valvulotomy, and the remaining 2 cases were transmitted to surgery department for transthoracic pulmonary valve perforation. The age at operation of the 12 patients who underwent transcatheter pulmonary valve perforation was 18 (14, 27) days, and the weight was (3.6±0.4) kg. The immediate postoperative right ventricular systolic pressure decreased significantly ((57±16) vs. (95±19) mmHg (1 mmHg=0.133 kPa), t=7.49, P<0.001), and the postoperative SpO2 was improved effectively (0.90±0.48 vs.0.75±0.09, t=-5.61, P<0.001). The follow-up time was 22 (7, 33) months for 12 patients who underwent transcatheter pulmonary valve perforation successfully. At the last follow-up, the ratio of right to left ventricular transverse diameter was significantly higher than that before operative (0.55±0.05 vs. 0.45±0.05, t=-3.27,P=0.007). Furthermore, the Z-scores of pulmonary valvular diameter (-0.78±0.23 vs. -1.73±0.56, t=-8.52, P<0.001) and the tricuspid valvular diameter (-0.52±0.12 vs. -1.46±0.38, t=-10.40, P<0.001) were all significantly higher than preoperative data. At last, all the patients achieved biventricular circulation without death or major complications. Conclusion: Transcatheter pulmonary valve perforation is a safe and effective therapy for neonatal PA-IVS, and its curative effect has been confirmed by the medium follow-up data.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Pulmonary Valve/surgery*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Pulmonary Atresia/surgery*
		                        			;
		                        		
		                        			Heart Defects, Congenital
		                        			
		                        		
		                        	
5.Circ_0018478 Inhibits the Fibrotic Phenotype of Cardiac Fibroblasts via Encoding Protein HERC4-193
Jia-xin FENG ; Ji-shen GUO ; Yu LIANG ; Jia-xue JIANG ; Hui LI ; Jin-dong XU ; Xian-hong FANG ; Zhi-xin SHAN
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(6):995-1004
		                        		
		                        			
		                        			ObjectiveTo investigate the effect of circ_0018478 on the fibrotic phenotype of cardiac fibroblasts and the potential mechanism involved. MethodsThe expression of circ_0018478 and its host gene of HECT and RLD domain containing E3 ubiquitin protein ligase 4 (HERC4) in the myocardium of patients with heart failure (HF) (n=28) and healthy donors (n=18) was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR) assay. The distribution of circ_0018478 was identified by fluorescence in situ hybridization (FISH) assay and RT-qPCR assay based on nucleocytoplasmic RNA in human AC16 cardiomyocytes. Actinomycin D and RNase R exonuclease digestion were used to test the stability of circ_0018478 in AC16 cells. RNA and protein expression of fibrosis-related genes was detected in mouse cardiac fibroblasts (mCFs) with adenovirus-mediated over-expression of circ_0018478. EdU staining and transwell migration assay were performed to detect the effects of circ_0018478 on mCFs proliferation and migration activities. The potential circ_0018478-translated protein in mCFs was identified by mass spectrometry (MS) shot-gun assay. HERC4-193 was inhibited by small interfering RNA (siRNA), and the effect of HERC4-193 knock-down on the fibrotic phenotype of mCFs with over-expression of circ_0018478 was studied. ResultsThe expression of circ_0018478 was up-regulated in the myocardium of HF patients, with no significant difference in its host gene of HERC4. The results of FISH and RT-qPCR assay showed that circ_0018478 was mainly in the cytoplasm of AC16 cardiomyocytes. The characteristic RNA stability of circ_0018478 was verified by Actinomycin D and RNase R assay, respectively. The enforced expression of circ_0018478 suppressed proliferation and migration of mCFs, and inhibited the expression of fibrosis-related genes in mCFs. The results of MS shot-gun assay and Western blotting showed that circ_0018478 could translate protein HERC4-193. Overexpression of the circ_0018478 and protein HERC4-193 could consistently inhibit the fibrotic phenotype of mCFs. Knock-down of HERC4-193 could attenuate the inhibitory effect of circ_0018478 on fibrosis-related gene expression in mCFs (P<0.05). ConclusionsCirc_0018478 inhibits the fibrotic phenotype of cardiac fibroblasts via translating HERC4-193 protein. 
		                        		
		                        		
		                        		
		                        	
6.Effects of bariatric surgery on sex hormones in male patients with obesity.
Shi Jin LUO ; Jun Xian ZHENG ; Yong Tong CHEN ; Zhi Wei XIE ; Zhuo Shen YANG ; Guo Ji CHEN ; Cun Chuan WANG ; Zhi Yong DONG
Chinese Journal of Gastrointestinal Surgery 2022;25(10):921-927
		                        		
		                        			
		                        			Objective: To analyze and evaluate the differences in sex hormones after laparoscopic Roux-en-Y Gastric Bypass Surgery (LRYGB) and laparoscopic sleeve gastrectomy (LSG) in male patients with obesity. Methods: This study was a retrospective cohort study. The inclusion criteria were (1) male patients with obesity who met the surgical indications of the "Chinese Guidelines for Surgical Treatment of Obesity and Type 2 Diabetes" (2019 Edition); (2) patients with a body mass index (BMI) of ≥27.5 kg/m2 and obesity-related metabolic diseases, or patients with severe obesity and a BMI of ≥35 kg/m2; and (3) sex hormone levels checked 1 year after surgery. The exclusion criteria included (1) patients with endocrine diseases (thyrotoxicosis, hyperprolactinemia) and hypothalamic-pituitary lesions and (2) those with severe major organ dysfunction who could not tolerate anesthesia or surgery. According to the above criteria, the clinical data of male patients with obesity admitted to the Gastrointestinal Surgery/Bariatric Center of the First Affiliated Hospital of Jinan University from October 2017 to January 2020 were included. A total of 52 male patients with obesity were included in this study. The mean age, body weight, BMI, and total testosterone level were (29.3±10.2) years, (123.6±35.4) kg, (40.1±11.1) kg/m2, and 7.6 (5.5, 9.1) nmol/L, respectively. Forty-five patients (86.5%) exhibited testosterone deficiency. Among all the patients, 29 underwent LSG (LSG group) and 23 underwent LRYGB surgery (LRYGB group). The main outcome measure was the change in sex hormone levels before and after bariatric surgery in all the patients. The secondary outcome measures were the comparison of changes in sex hormone levels before and after LSG and LRYGB. Results: Pearson correlation analysis showed that preoperative estradiol was positively correlated with waist circumference (R=0.299, P<0.05), hip circumference (R=0.326, P<0.05), and chest circumference (R=0.388, P<0.05). Testosterone was negatively correlated with BMI (R=-0.563, P<0.01), waist circumference (R=-0.521, P<0.01), hip circumference (R=-0.456, P<0.01), chest circumference (R=-0.600, P<0.01), and neck circumference (R=-0.547, P<0.01). One year following bariatric surgery, the serum testosterone (7.6 [5.5, 9.1] nmol/L vs. 13.6 [10.5, 15.4] nmol/L, Z=-5.910, P<0.001), follicle-stimulating hormone (4.7 [2.7, 5.3] IU/L vs. 6.5 [3.6, 7.8] IU/L, Z=-4.658, P<0.001), and progesterone (1.2 [0.4, 1.5] nmol/L vs. 1.9 [0.8, 1.3] nmol/L, Z=-2.542, P=0.011) levels were significantly higher in all the patients. Both estradiol (172.8 [115.6, 217.5] pmol/L vs. 138.3 [88.4, 168.1] pmol/L, Z=-2.828, P=0.005) and prolactin (11.4 [6.4, 14.6] mIU/L vs. 8.6 [4.8, 7.3] mIU/L, Z=-2.887, P=0.004) levels were decreased. In addition to prolactin levels in the LRYGB group, there were statistically significant differences in the levels of estradiol (P=0.030), follicle-stimulating hormone (P < 0.001), luteinizing hormone (P=0.033), progesterone (P=0.034), and testosterone (P<0.001) compared with their preoperative levels. In the LSG group, there were statistically significant differences in the levels of follicle-stimulating hormone (P=0.011), prolactin (P=0.023), and testosterone (P<0.001) compared with their preoperative levels. Conclusion: The degree of obesity in men was negatively correlated with testosterone levels. Both LRYGB and LSG can significantly improve sex hormone levels in male patients with obesity, and testosterone levels show a significant increase after surgery.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Bariatric Surgery
		                        			;
		                        		
		                        			Body Mass Index
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/surgery*
		                        			;
		                        		
		                        			Estradiol
		                        			;
		                        		
		                        			Follicle Stimulating Hormone
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Luteinizing Hormone
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Obesity/surgery*
		                        			;
		                        		
		                        			Progesterone
		                        			;
		                        		
		                        			Prolactin
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Testosterone
		                        			;
		                        		
		                        			Weight Loss
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
7.Association of nutritional status with clinical outcomes of stroke patients with acute anterior circulation large vessel occlusion after emergency endovascular treatment.
Yi SUN ; Ya Chen JI ; Kang Fei WU ; Hao WANG ; Ya Peng GUO ; Xiang Jun XU ; Xian Jin SHANG ; Qian YANG ; Xian Jun HUANG ; Zhi Ming ZHOU
Journal of Southern Medical University 2022;42(9):1397-1402
		                        		
		                        			OBJECTIVE:
		                        			To explore the influence of nutritional status on 90-day functional outcomes of stroke patients with acute large vessel occlusion in the anterior circulation after endovascular treatment (EVT).
		                        		
		                        			METHODS:
		                        			We retrospectively analyzed the baseline, laboratory, surgical and 90-day follow-up data of patients with stroke resulting from acute large vessel occlusion in the anterior circulation, who underwent emergency endovascular treatment in our hospital from July, 2015 to December, 2020. A favorable outcome was defined as a modified Rankin scale score ≤2 at 90 days. Univariate and multivariate regression analyses were performed to explore the relationship between nutritional status and 90-day functional outcomes of the patients.
		                        		
		                        			RESULTS:
		                        			A total of 459 patients (mean age of 68.29±11.21 years, including 260 males) were enrolled in this study. According to their prognostic nutritional index (PNI), the patients were divided into normal nutrition group (392 cases, 85.4%), moderate malnutrition group (44 cases, 9.6%), and severe malnutrition group (23 cases, 5.0%). Univariate analysis showed that the patients with good clinical outcomes had a lower proportion of malnutrition with a younger age, a lower rate of diabetes, lower baseline blood pressure, lower baseline NIHSS score, higher baseline ASPECT score, and higher rates of good collateral circulation and complete vascular recanalization. Multivariate analysis showed that in addition to age, diabetes, baseline systolic blood pressure, successful recanalization, baseline ASPECT score, baseline NIHSS score and collateral circulation, a greater PNI was a protective factor for a good 90-day outcome of patients after EVT (moderate vs severe: OR=0.245, 95% CI: 0.066-0.908, P=0.035; normal vs severe: OR=0.185, 95% CI: 0.059-0.581, P=0.004).
		                        		
		                        			CONCLUSION
		                        			Nutritional status an important factor affecting the 90-day outcomes after EVT of stroke patients with acute large vessel occlusion in the anterior circulation.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Brain Ischemia/etiology*
		                        			;
		                        		
		                        			Endovascular Procedures/methods*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Malnutrition/etiology*
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Nutritional Status
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Stroke/surgery*
		                        			;
		                        		
		                        			Thrombectomy/methods*
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
8.Circular RNA circ_0036176 Inhibiting Myocardial Fibrosis Via Sponging miRNA-218-5p
Zhi-qi HUANG ; Yu-min YAN ; Jing GUO ; Ji-shen GUO ; Jie-ning ZHU ; Xian-hong FANG ; Jin-dong XU ; Zhi-xin SHAN
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(1):61-69
		                        		
		                        			
		                        			ObjectiveTo investigate the biological effect of circ_0036176 on myocardial fibrosis. MethodsLevels of circ_0036176 and its host gene Myo9a were determined by real-time quantitative polymerase chain reaction (RT-qPCR) assay in human myocardial tissue, including 22 healthy organ donors and 26 patients with heart failure (HF). A cell model of angiotensin Ⅱ (Ang-Ⅱ)-induced fibrosis in human atrial fibroblasts (HAFs) was achieved. To test the typical ring structure of circ_0036176, actinomycin D treatment and RNase R exonuclease digestion were performed. The expression of fibrosis-related gene in HAFs with overexpression of circ_0036176 was detected at mRNA and protein level. To select miRNAs that can effectively bind to circ_0036176, dual luciferase reporter gene assay and RNA antisense purification assay (RAP) were conducted, respectively. The neonatal mouse cardiac fibroblasts (mCFs) were used to study whether mir-218-5p mediates the effect of circ_0036176 on myocardial fibrosis phenotype. ResultsThe expression of circ_0036176 was up-regulated in the myocardium of HF patients (P<0.001), and the expression of circ_0036176 and the host gene Myo9a was down-regulated in Ang-Ⅱ-induced HAFs (P<0.01). In response to actinomycin D treatment and RNase R exonuclease digestion, circ_0036176 was more stable than Myo9a mRNA. The expression of COL1A1, COL3A1, TGF-β1 and ACTA2 was down-regulated in HAFs with overexpression of circ_0036176 (P<0.05). Results of dual luciferase reporter gene assay and RAP assay confirmed the interaction between miR-218-5p and circ_0036176. Overexpression of miR-218-5p could promote the expression of fibrosis-related genes, and attenuate the inhibitory effect of circ_0036176 on cardiac fibrosis. ConclusionsCirc_0036176 is up-regulated in the myocardium of HF patients, and circ_0036176 inhibits the expression of fibrosis-related gene through sponging miR-218-5p in CFs. 
		                        		
		                        		
		                        		
		                        	
9.Visual Detection of Vibrio parahaemolyticus using Combined CRISPR/Cas12a and Recombinase Polymerase Amplification.
Han Ji JIANG ; Rong TAN ; Min JIN ; Jing YIN ; Zhi Xian GAO ; Hai Bei LI ; Dan Yang SHI ; Shu Qing ZHOU ; Tian Jiao CHEN ; Dong YANG ; Jun Wen LI
Biomedical and Environmental Sciences 2022;35(6):518-527
		                        		
		                        			Objective:
		                        			To establish an ultra-sensitive, ultra-fast, visible detection method for Vibrio parahaemolyticus (VP) .
		                        		
		                        			Methods:
		                        			We established a new method for detecting the tdh and trh genes of VP using clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 12a (CRISPR/Cas12a) combined with recombinase polymerase amplification and visual detection (CRISPR/Cas12a-VD).
		                        		
		                        			Results:
		                        			CRISPR/Cas12a-VD accurately detected target DNA at concentrations as low as 10 -18 M (single molecule detection) within 30 min without cross-reactivity against other bacteria. When detecting pure cultures of VP, the consistency of results reached 100% compared with real-time PCR. The method accurately analysed pure cultures and spiked shrimp samples at concentrations as low as 10 2 CFU/g.
		                        		
		                        			Conclusion
		                        			The novel CRISPR/Cas12a-VD method for detecting VP performed better than traditional detection methods, such as real-time PCR, and has great potential for preventing the spread of pathogens.
		                        		
		                        		
		                        		
		                        			CRISPR-Cas Systems
		                        			;
		                        		
		                        			Nucleic Acid Amplification Techniques/methods*
		                        			;
		                        		
		                        			Recombinases/genetics*
		                        			;
		                        		
		                        			Vibrio parahaemolyticus/genetics*
		                        			
		                        		
		                        	
10.Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease.
Xin WANG ; Si-Lin PAN ; Zhan-Hui DU ; Zhi-Xian JI ; Gang LUO ; Hong-Xiao SUN ; Shu-Jing MA
Chinese Journal of Contemporary Pediatrics 2022;24(4):399-404
		                        		
		                        			OBJECTIVES:
		                        			To examine the association between duration of fever before intravenous immunoglobulin (IVIG) treatment and IVIG resistance in children with Kawasaki disease (KD).
		                        		
		                        			METHODS:
		                        			A retrospective analysis was performed on the medical data of 317 children with KD who were admitted from January 2018 to December 2020. According to the duration of fever before IVIG treatment, they were divided into two groups: short fever duration group (≤4 days) with 92 children and long fever duration group (>4 days) with 225 children. According to the presence or absence of IVIG resistance, each group was further divided into a drug-resistance group and a non-drug-resistance group. Baseline data and laboratory results were compared between groups. A multivariate logistic regression analysis was used to identify the influencing factors for IVIG resistance.
		                        		
		                        			RESULTS:
		                        			In the short fever duration group, 19 children (20.7%) had IVIG resistance and 5 children (5.4%) had coronary artery aneurysm, and in the long fever duration group, 22 children (9.8%) had IVIG resistance and 19 children (8.4%) had coronary artery aneurysm, suggesting that the short fever duration group had a significantly higher rate of IVIG resistance than the long fever duration group (P<0.05), while there was no significant difference in the incidence rate of coronary artery aneurysm between the two groups (P>0.05). In the short fever duration group, compared with the children without drug resistance, the children with drug resistance had a significantly lower level of blood sodium and significantly higher levels of procalcitonin, C-reactive protein, and N-terminal B-type natriuretic peptide before treatment (P<0.05). In the long fever duration group, the children with drug resistance had significantly lower levels of blood sodium and creatine kinase before treatment than those without drug resistance (P<0.05). The multivariate logistic regression analysis showed that a reduction in blood sodium level was associated with IVIG resistance in the long fever duration group (P<0.05).
		                        		
		                        			CONCLUSIONS
		                        			IVIG resistance in children with KD varies with the duration of fever before treatment. A reduction in blood sodium is associated with IVIG resistance in KD children with a duration of fever of >4 days before treatment.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Coronary Aneurysm/drug therapy*
		                        			;
		                        		
		                        			Fever/etiology*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulins, Intravenous/therapeutic use*
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Mucocutaneous Lymph Node Syndrome/drug therapy*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Sodium/therapeutic use*
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail